Vaccine clinical trials to treat and potentially prevent type 1 diabetes 28 April 2021 An oral vaccine that could treat or potentially prevent type 1 diabetes is in clinical trials at the University of Queensland. Associate Professor Emma Hamilton-Williams hopes the research will end the lifelong dependency on insulin. With the support of the Diabetes Australia Research Program researchers are aiming to create a vaccine that can re-educate the t-cells in the immune system to stop the pathogenic process that leads them to destroy the insulin-producing cells in the pancreas. You can watch the video here:
News 5 November 2025 Registrations now open for the region’s largest diabetes congress! The countdown is on, with registrations and abstract submissions now open for one of the most significant international diabetes events... Continue Reading
Blog 5 November 2025 Celebrating a decade of impact: thank you, Future Generation Australia Thank you FGX, for believing in our kids, for standing beside them for the past 10 years, and for helping us create a brighter, healthier future. Continue Reading
Partners 4 November 2025 Chemist2U partnership is convenience that gives back Our Chemist2U partnership offers convenience, safety, and supports the diabetes community Continue Reading